Direkt zum Inhalt
Merck
  • Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro.

Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro.

Bioorganic & medicinal chemistry letters (2008-08-02)
Ryuichi Ueoka, Yuji Komizu, Yoko Matsumoto, Yu Zhong, Ritsuko Tanaka, Naoki Yamamoto
ZUSAMMENFASSUNG

A good correlation between fifty-percent inhibitory concentration (IC(50)) of hybrid liposomes (HL) composed of dimyristoylphosphatidylcholine and polyoxyethylene(n) dodecyl ether on the growth of MOLT-4/IIIB cells (MOLT-4 cells chronically infected with human immunodeficiency virus (HIV)) and the membrane fluidity of HL was obtained. Furthermore, the huge enhancement of virus production was observed in the latently HIV-infected (J(22)-HL-60) cells after the treatment with HL.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Decaethylenglykolmonododecylether, nonionic surfactant
Sigma-Aldrich
Thesit®, for membrane research
Sigma-Aldrich
1,2-Dimyristoyl-sn-Glycero-3-Phosphocholin, ≥99%
Sigma-Aldrich
Octaethylenglykol-monododecylether, ≥98% (GC)
Sigma-Aldrich
Brij® L23 -Lösung, 30 % (w/v) in H2O
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Octaethylenglykol-monododecylether, BioXtra, ≥98.0% (GC)
Sigma-Aldrich
Tetraethylenglykol-monododecylether, BioXtra, ≥98.0% (GC)
Sigma-Aldrich
Brij® L4, average Mn ~362
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography
Sigma-Aldrich
ECO BRIJ® L4, average Mn ~362
Sigma-Aldrich
ECO Brij® L23